Results: 29

Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Antifibrinolytics

Abstract The use of strategies to reduce blood loss and transfusions is essential in the treatment of surgical patients, including in complex cardiac surgeries and those that use cardiopulmonary bypass. Antifibrinolytics, such as epsilon-aminocaproic acid (EACA) and tranexamic acid (TXA), are widely used...

Orthognathic surgery in a patient with von Willebrand disease: case report

Braz. j. oral sci; 23 (), 2024
Aim: This study aims to report the perioperative management of a patient with von Willebrand disease (vWd) who underwent orthognathic surgery. The report follows the guidelines of the Case Report Guidelines (CARE) and focuses on the steps taken to prevent bleeding during the surgical procedure. Methods: ...

El ácido tranexámico podría reducir la mortalidad en pacientes con lesiones traumáticas agudas
Tranexamic acid could reduce mortality in patients with acute traumatic injuries

El empleo del ácido tranexámico en ortopedia y traumatología
The use of tranexamic acid in orthopedics and traumatology

Introducción: En las dos últimas décadas se han incrementado las publicaciones sobre el empleo del ácido tranexámico en diferentes especialidades quirúrgicas; entre ellas, la cirugía ortopédica y traumatológica. Objetivo: Demostrar la importancia del ácido tranexámico en la cirugía electiva y...

Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials

Braz. J. Anesth. (Impr.); 73 (4), 2023
Abstract Background Postpartum Hemorrhage (PPH) is one of the main causes of maternal mortality, mainly in the poorest regions of the world, drawing attention to the need for strategies for preventing it. This study aims to evaluate the efficacy of prophylactic administration of Tranexamic Acid (TXA) in...

Clinical use of tranexamic acid: evidences and controversies

Braz. J. Anesth. (Impr.); 72 (6), 2022
Abstract Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. Although it mainly acts as a fibrinolysis inhibitor, it also has an anti-inflammatory effect, and may help attenuate th...

Aplicación tópica de ácido tranexámico en urología: ¿Una alternativa de manejo?

Los agentes antifibrinolíticos, como el ácido tranexámico, por medio de su administración endovenosa se usan en distintos procedimientos quirúrgicos para prevenir la pérdida de sangrado perioperatorio.[1] Este medicamento es un derivado sintético análogo de la lisina que bloquea los sititos de un...

Uso del ácido tranexámico en la hemorragia posparto: ¿qué debemos conocer?

Rev. chil. anest; 51 (3), 2022
Postpartum hemorrhage is a common cause of death and complications worldwide in women who give birth. In low-income countries, it is the leading cause of maternal death and a significant public health problem. It has been observed that patients with postpartum hemorrhage have an early increase in fibrino...

Efecto de la infusión de ácido tranexámico en altas dosis por 24 horas en las muertes y eventos tromboembólicos en pacientes con hemorragia digestiva (HALT-IT): un estudio internacional aleatorizado, doble ciego y controlado con placebo

Gastroenterol. latinoam; 33 (1), 2022

Uso del ácido tranexámico en la hemorragia posparto: ¿qué debemos conocer?

Rev. chil. anest; 51 (6), 2022
Postpartum hemorrhage is a common cause of death and complications worldwide in women who give birth. In low-income countries, it is the leading cause of maternal death and a significant public health problem. It has been observed that patients with postpartum hemorrhage have an early increase in fibrino...